1-(2-(naphth-2-yl)ethyl)-4-(3-trifluoromethylphenyl)-1,2,5,6-tetrahydropyridine hydrochloride,
1-(2-(naphth-2-yl)ethyl)-4-(trifluoromethylphenyl)-1,2,5,6-tetrahydropyridine hydrochloride,
SR 57746A,
SR-57746A,
SR57746A,
xaliproden,
xaliproden hydrochloride,
Xaliproden hydrochloride,
90494-79-4,
SR 57746A,
SR-57746A,
UNII-44D5EE8E26,
44D5EE8E26,
1-(2-(Naphth-2-yl)ethyl)-4-(3-trifluoromethylphenyl)-1,2,5,6-tetrahydropyridine hydrochloride,
1,2,3,6-TETRAHYDRO-1-[2-(2-NAPHTHALENYL)ETHYL]-4-[3-(TRIFLUOROMETHYL)PHENYL]-PYRIDINE HYDROCHLORIDE,
DSSTox_CID_26724,
DSSTox_RID_81854,
DSSTox_GSID_46724,
1,2,3,6-Tetrahydro-1-[2-(2-naphthalenyl)ethyl]-4-[3-(trifluoromethyl)phenyl]pyridine hydrochloride,
Pyridine, 1,2,3,6-tetrahydro-1-(2-(2-naphthalenyl)ethyl)-4-(3-(trifluoromethyl)phenyl)-, hydrochloride,
CAS-90494-79-4,
NCGC00167574-01,
SR-57746,
Xaprila,
AC1L2UOQ,
AC1Q3C8K,
MLS004712059,
SCHEMBL116721,
Xaliproden hydrochloride (JAN),
CHEMBL3183486,
DTXSID5046724,
CHEBI:32302,
CTK5G8025,
WVHBEIJGAINUBW-UHFFFAOYSA-N,
Tox21_112567,
AKOS024457131,
Tox21_112567_1,
NCGC00167574-03,
AN-16671,
CC-02740,
SMR003475020,
LS-132040,
FT-0642171,
D01537,
Xaliproden hydrochloride, >=97% (HPLC), solid,
494X794,
C-35536,
1-(2-(naphthalen-2-yl)ethyl)-4-(3-(trifluoromethyl)phenyl)-1,2,3,6-tetrahydropyridine hydrochloride,
1-(2-naphthalen-2-ylethyl)-4-[3-(trifluoromethyl)phenyl]-3,6-dihydro-2H-pyridine hydrochloride,
1-[2-(2-naphthyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine hydrochloride,
1-[2-(2-naphthyl)ethyl]-4-[3-(trifluoromethyl)phenyl]-3,6-dihydro-2H-pyridine hydrochloride,
1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine hydrochloride,
Xaliproden,
Xaliprodenhydrochloride,
Xaliproden (hydrochloride),
C24H22F3N.ClH,
C24-H22-F3-N.Cl-H,
CS-AD-00610,
SR57746A,
AR-1L8230,
CID128918,
C462299,
Pyridine, 1,2,3,6-tetrahydro-1-(2-(2-naphthalenyl)ethyl)-4-(3-(trifluoromethyl)phenyl)-,
1-(2-(naphth-2-yl)ethyl)-4-(trifluoromethylphenyl)-1,2,5,6-tetrahydropyridine hydrochloride,
135354-02-8,
96573-23-8,